Performance status-2 - Symptomatic, 50 in bed Posts on Medivizor
Navigation Menu

Performance status-2 – Symptomatic, 50 in bed Posts on Medivizor

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Posted by on Feb 6, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to investigate using rituximab (Rituxan) and high-dose methylprednisolone (HDMP; Medrol) as a treatment for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).   This study concluded that this treatment is a good option for elderly and frail patients and can work as a bridge to...

Read More

Searching for patients with solid tumors with abnormal genetic changes to trial an experimental medication

Searching for patients with solid tumors with abnormal genetic changes to trial an experimental medication

Posted by on Apr 30, 2021 in Breast cancer | 0 comments

In a nutshell This study is searching for participants with advanced solid tumors including breast cancer to examine the safety and effectiveness of experimental drug avapritinib (AYVAKIT). The main outcomes to be measured are the response to treatment and side effects. This trial is being conducted in Texas, US. The details Some cancers grow as a...

Read More

Looking for patients with relapsed or refractory multiple myeloma to trial a treatment combination

Looking for patients with relapsed or refractory multiple myeloma to trial a treatment combination

Posted by on Jan 28, 2021 in Multiple Myeloma | 0 comments

In a nutshell This trial is aiming to examine the effectiveness of combination therapy with venetoclax (Venclexta), daratumumab (Darzalex), and dexamethasone (Ozurdex) with or without bortezomib (Velcade) for unresponsive or relapsed multiple myeloma (MM). The main outcome that is to be measured is the response rate, time to response,...

Read More

Searching for patients with advanced non-small cell lung cancer to trial a radiation treatment

Searching for patients with advanced non-small cell lung cancer to trial a radiation treatment

Posted by on Nov 8, 2020 in Lung cancer | 0 comments

In a nutshell This trial is looking at the effectiveness of Quad Shot (QS) radiation therapy (RT) to relieve symptoms in patients with advanced non-small-cell lung cancer (NSCLC). The main outcome that is to be measured is the occurrence of side effects over the course of 3-months. This trial is being carried out in New Jersey and New York,...

Read More

Looking for participants to test a chemo-radiotherapy combination for operable rectal cancer

Looking for participants to test a chemo-radiotherapy combination for operable rectal cancer

Posted by on Aug 23, 2020 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of short-course radiation therapy and TAS-102 (Lonsurf) plus oxaliplatin (Eloxatin) chemotherapy in rectal cancer. The main outcome to be measured will be the change in treatment response. This study is being conducted in the US. The details Colorectal cancer is one of...

Read More

Looking for patients with multiple myeloma to try a maintenance therapy combination after SCT

Posted by on Sep 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial will compare the effectiveness of two maintenance therapies in patients with multiple myeloma (MM) after a stem cell transplant (SCT). The main outcome to be measured will be the average time from treatment until death due to any cause.  The details Maintenance therapy is commonly given after SCT to help delay...

Read More

Looking for participants to test a vaccine for the treatment of advanced colorectal cancer

Posted by on Sep 10, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1b trial is examining the effectiveness and safety of a vaccine treatment, ATP128, in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to the treatment and treatment toxicity. This trial is being conducted in Arizona and California, US. The details Colorectal cancer is the...

Read More

Evaluating GVDex chemotherapy for patients with recurrent or persistent Hodgkin’s lymphoma

Evaluating GVDex chemotherapy for patients with recurrent or persistent Hodgkin’s lymphoma

Posted by on Aug 19, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if GVDex is as effective and safe as GVDoxil for treating Hodgkin's lymphoma (HL) that has come back or stopped responding to treatment. The authors found that GVDex was as effective as GVDoxil, with fewer side effects. Some background For most patients with HL, primary therapy is highly effective....

Read More

Does the modification of chemotherapy reduce heart disease side effects in patients with Hodgkin lymphoma?

Does the modification of chemotherapy reduce heart disease side effects in patients with Hodgkin lymphoma?

Posted by on Aug 4, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if a modified version of doxorubicin (Adriamycin) in ABVD chemotherapy was safe and effective in patients with Hodgkin’s lymphoma who had heart disease. This study found that this regimen was safer and just as effective as conventional ABVD. Some background Hodgkin’s lymphoma (HL) is a cancer of white...

Read More